Dead cells disrupt immune responses and undermine defense against infection, new research has found.
The study, led by scientists at the University of Sheffield, revealed that cells which are programmed to die, a process known as apoptosis, can disrupt the normal function of immune cells, called macrophages. This can impact on how well they respond to wounds and patrol the body to seek out infection.
Our macrophages are needed at wound sites to prevent infection and to aid healing processes, but these white blood cells can also cause and worsen many human diseases, including cancer, heart disease and neurodegenerative disorders.
The findings, published in the journal PLOS Biology, show that immune cells prioritise the clearance of dead cells, which overrides their normal migration to sites of injury, impairing immune responses.
The research, which seeks to understand how immune cells are controlled, could help pave the way for new therapies to manipulate these cells and accelerate healing processes. This study gives scientists new insights into the mechanisms that control immune cells within our bodies, such as how they get to and are kept at sites of injuries.
Dr. Iwan Evans, from the Department of Infection, Immunity and Cardiovascular Disease at the University of Sheffield who co-author of the paper, said, "Billions of cells die within our bodies on a daily basis and many of these are removed and digested by our immune cells.
"If this removal process goes wrong it can lead to damaging autoimmune conditions. Excessive or inappropriate immune responses worsen or cause a very broad range of human diseases from cancer to neurodegeneration.
"This work studies fundamental biological processes that are going on inside our bodies everyday that are necessary to keep us healthy."
The research to investigate the interactions between dying cells and immune cells was conducted using fruit flies which contain macrophage-like cells highly similar to our own immune cells. The new study also uncovered a novel role for a protein called Six-Microns-Under (or Simu) in keeping immune cells at sites of injury. Without this protein the macrophages left wound sites precociously.
Hannah Roddie, fellow co-author of the study and research associate in the Department of Infection, Immunity and Cardiovascular Disease at the University of Sheffield, said, "The study shows that the way fruit fly blood cells respond to injuries and dying cells is even more similar to how our own immune cells respond than previously thought. We are now looking into what signals macrophages use to track down dying cells and how they choose between the dead cells and wounds. We're fascinated to understand how immune cells are kept at the sites of injuries."
Source: University of Sheffield
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.